Cunningham Owens, DG. A Guide to the Extrapyramidal Side-Effects of Neuroleptic Drugs.
Cambridge University Press, 1999.
Fenton, WS. Prevalence of spontaneous dyskinesia in schizophrenia. J Clin Psychiatry
2000; 61 (suppl 4): 10–4.
Owens, DG, Johnstone, EC, Frith, CD. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry
1982; 39: 452–61.
McCreadie, RG, Thara, R, Kamath, S, Padmavathy, R, Latha, S, Mathrubootham, N, et al Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry
1996; 168: 221–6.
Whitty, PF, Owoeye, O, Waddington, JL. Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology. Schizophr Bull
2009; 35: 415–24.
Crow, TJ, Owens, DG, Johnstone, EC, Cross, AJ, Owen, F. Does tardive dyskinesia exist?
Mod Probl Pharmacopsychiatry
1983; 21: 206–19.
Casey, DE. Tardive dyskinesia: pathophysiology and animal models. J Clin Psychiatry
2000; 61 (suppl 4): 5–9.
Klawans, HL, Weiner, WJ. The pharmacology of choreatic movement disorders. Prog Neurobiol
1976; 6: 49–80.
Gerlach, J. Tardive dyskinesia. Dan Med Bull
1979; 26: 209–45.
Mackay, AV, Iversen, LL, Rossor, M, Spokes, E, Bird, E, Arregui, A, et al Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry
1982; 39: 991–7.
Cross, AJ, Crow, TJ, Ferrier, IN, Johnson, JA, Johnstone, EC, Owen, F, et al Chemical and structural changes in the brain in patients with movement disorder. Psychopharmacology Suppl
1985; 2: 104–10.
Kornhuber, J, Riederer, P, Reynolds, GP, Beckmann, H, Jellinger, K, Gabriel, E. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. J Neural Transm
1989; 75: 1–10.
Adler, CM, Malhotra, AK, Elman, I, Pickar, D, Breier, A. Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesia. Neuropsychopharmacology
2002; 26: 295–300.
Owens, DG, Johnstone, EC, Crow, TJ, Frith, CD, Jagoe, JR, Kreel, L. Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychol Med
1985; 15: 27–41.
Hoffman, WF, Casey, DE. Computed tomographic evaluation of patients with tardive dyskinesia. Schizophr Res
1991; 5: 1–12.
Mion, CC, Andreasen, NC, Arndt, S, Swayze, VW 2nd, Cohen, GA. MRI abnormalities in tardive dyskinesia. Psychiatry Res
1991; 40: 157–66.
Elkashef, AM, Buchanan, RW, Gellad, F, Munson, RC, Breier, A. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study. Am J Psychiatry
1994; 151: 752–5.
Waddington, JL, O'Callaghan, E, Buckley, P, Madigan, C, Redmond, O, Stack, JP, et al Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging. Br J Psychiatry
1995; 167: 41–4.
Wright, IC, Rabe-Hesketh, S, Woodruff, PW, David, AS, Murray, RM, Bullmore, ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry
2000; 157: 16–25.
Brandt, GN, Bonelli, RM. Structural neuroimaging of the basal ganglia in schizophrenic patients: a review. Wien Med Wochenschr
2008; 158: 84–90.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV).
Simpson, GM, Lee, JH, Zoubok, B, Gardos, G. A rating scale for tardive dyskinesia. Psychopharmacology (Berl)
1979; 64: 171–9.
Schooler, NR, Kane, JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry
1982; 39: 486–7.
Peralta, V, Cuesta, MJ. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res
1994; 53: 31–40.
Del Ser, T, Gonzalez-Montalvo, JI, Martinez-Espinosa, S, Delgado-Villapalos, C, Bermejo, F. Estimation of premorbid intelligence in Spanish people with the Word Accentuation Test and its application to the diagnosis of dementia. Brain Cogn
1997; 33: 343–56.
Wechsler, D. Wechsler Adult Intelligence Scale (3rd edn).
The Psychological Corporation, 1997.
Good, CD, Johnsrude, IS, Ashburner, J, Henson, RN, Friston, KJ, Frackowiak, RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage
2001; 14: 21–36.
Smith, SM, Jenkinson, M, Woolrich, MW, Beckmann, CF, Behrens, TE, Johansen-Berg, H, et al Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage
2004; 23 (suppl 1): S208–19.
Smith, SM. Fast robust automated brain extraction. Hum Brain Mapp
2002; 17: 143–55.
Bartels, M, Themelis, J. Computerized tomography in tardive dyskinesia. Evidence of structural abnormalities in the basal ganglia system. Arch Psychiatr Nervenkr
1983; 233: 371–9.
Bai, YM, Chou, KH, Lin, CP, Chen, IY, Li, CT, Yang, KC, et al White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study. Schizophr Res
2009; 109: 167–81.
Alexander, GE, DeLong, MR, Strick, PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci
1986; 9: 357–81.
Parent, A, Hazrati, LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev
1995; 20: 91–127.
Cummings, JL. Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci
1995; 769: 1–13.
Quinn, N, Schrag, A. Huntington's disease and other choreas. J Neurol
1998; 245: 709–16.
Chua, SE, Cheung, C, Cheung, V, Tsang, JT, Chen, EY, Wong, JC, et al Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res
2007; 89: 12–21.
Leung, M, Cheung, C, Yu, K, Yip, B, Sham, P, Li, Q, et al Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull
2011; 37: 199–211.
McCreadie, RG, Thara, R, Padmavati, R, Srinivasan, TN, Jaipurkar, SD. Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Arch Gen Psychiatry
2002; 59: 332–6.
Mittal, VA, Daley, M, Shiode, MF, Bearden, CE, O'Neill, J, Cannon, TD. Striatal volumes and dyskinetic movements in youth at high-risk for psychosis. Schizophr Res
2010; 123: 68–70.
Bjorklund, A, Dunnett, SB. Dopamine neuron systems in the brain: an update. Trends Neurosci
2007; 30: 194–202.
Dorph-Petersen, KA, Pierri, JN, Perel, JM, Sun, Z, Sampson, AR, Lewis, DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology
2005; 30: 1649–61.
Ho, BC, Andreasen, NC, Ziebell, S, Pierson, R, Magnotta, V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry
2011; 68: 128–37.